- Home
- PII vs XENE Comparison
PII vs XENE Comparison
Compare PII & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PII
- XENE
- Stock Information
- Founded
- PII 1954
- XENE 1996
- Country
- PII United States
- XENE Canada
- Employees
- PII N/A
- XENE N/A
- Industry
- PII Recreational Games/Products/Toys
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- PII Consumer Discretionary
- XENE Health Care
- Exchange
- PII Nasdaq
- XENE Nasdaq
- Market Cap
- PII 2.6B
- XENE 2.9B
- IPO Year
- PII 1987
- XENE 2014
- Fundamental
- Price
- PII $57.32
- XENE $36.21
- Analyst Decision
- PII Hold
- XENE Strong Buy
- Analyst Count
- PII 11
- XENE 11
- Target Price
- PII $45.30
- XENE $52.73
- AVG Volume (30 Days)
- PII 1.2M
- XENE 672.5K
- Earning Date
- PII 10-21-2025
- XENE 11-11-2025
- Dividend Yield
- PII 4.68%
- XENE N/A
- EPS Growth
- PII N/A
- XENE N/A
- EPS
- PII N/A
- XENE N/A
- Revenue
- PII $6,961,400,000.00
- XENE $7,500,000.00
- Revenue This Year
- PII N/A
- XENE N/A
- Revenue Next Year
- PII $4.22
- XENE $256.34
- P/E Ratio
- PII N/A
- XENE N/A
- Revenue Growth
- PII N/A
- XENE N/A
- 52 Week Low
- PII $30.92
- XENE $26.74
- 52 Week High
- PII $86.51
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- PII 53.31
- XENE 44.80
- Support Level
- PII $57.28
- XENE $38.13
- Resistance Level
- PII $60.57
- XENE $39.55
- Average True Range (ATR)
- PII 1.88
- XENE 0.97
- MACD
- PII -0.17
- XENE -0.48
- Stochastic Oscillator
- PII 46.37
- XENE 0.55
About PII Polaris Inc.
Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.